Skip to main content

DOLIVER ADVISORS, LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 938077 HOUSTON, TX

Position in BCRX

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$3,743,280
+$179,678 QoQ
Shares Held
374,328
0.0% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#73
of 316 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DOLIVER ADVISORS, LP holds $3,743,280 across 1 Drug Manufacturers - Specialty & Generic name. BCRX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
This page
374,328 $3,743,280

All Filings in BCRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,743,280 374,328
2026-03-31 $3,563,602 374,328
2025-12-31 $2,139,758 274,328
2025-09-30 $2,082,149 274,328
2025-06-30 $2,457,978 274,328
2025-03-31 $557,460 74,328
2024-12-31 $558,946 74,328
2024-09-30 $615,600 81,000
2024-06-30 $500,580 81,000
2024-03-31 $411,480 81,000
2023-12-31 $485,190 81,000
2023-09-30 $573,480 81,000
2023-06-30 $570,240 81,000
2023-03-31 $675,540 81,000
2022-12-31 $929,880 81,000
2022-09-30 $1,020,600 81,000
2022-06-30 $856,980 81,000
2022-03-31 $1,317,060 81,000
2021-12-31 $1,385,000 100,000
2021-09-30 $1,437,000 100,000